Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Errant epitopes from arginine methylated SARS-CoV-2 proteins predisposing to autoimmune diseases

EF 2021-22

Résumé
The SARS-CoV-2 nucleocapsid (N) protein is the most abundant protein expressed in virions and infected cells. It contains five RGG/RG motifs, preferential sites for protein arginine methyltransferases (PRMTs). Notably, R95 and R177 are sites of PRMT1 methylation previously identified by our lab (Cai et al., 2021) and are also predicted B and T cell epitopes. Autoantibodies have been reported in SARS-CoV-2-infected patients, and autoantibodies against arginine methylated residues have been isolated from patients with systemic lupus erythematosus (SLE). We propose that SARS-CoV-2-infected patients may develop antibodies against arginine methylated N protein that overlap with self-arginine methylated proteins and lead to autoimmune disease. To test this, we propose performing a series of ELISAs using differentially methylated peptides and plasma from SARS-CoV-2-infected patients. We also plan to perform a series of in vitro methylation assays and mass spectrometry to identify other SARS-CoV-2 proteins modified by PRMTs. These findings will have an impact on why certain patients post-SARS-CoV-2 infection develop persistent illnesses, especially autoimmune diseases. This project will also identify new post-translational modifications that may regulate SARS-CoV-2 biology.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
466499
Name
Khan Sarah M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Errant epitopes from arginine methylated SARS-CoV-2 proteins predisposing to autoimmune diseases
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Arginine Methylation; Autoantibodies; Autoimmune Disease; Covid-19; Long-Covid; Methylated Antibodies; Nucleocapsid Protein; Prmt1; Prmts; Sars-Cov-2
Abstract
The SARS-CoV-2 nucleocapsid (N) protein is the most abundant protein expressed in virions and infected cells. It contains five RGG/RG motifs, preferential sites for protein arginine methyltransferases (PRMTs). Notably, R95 and R177 are sites of PRMT1 methylation previously identified by our lab (Cai et al., 2021) and are also predicted B and T cell epitopes. Autoantibodies have been reported in SARS-CoV-2-infected patients, and autoantibodies against arginine methylated residues have been isolated from patients with systemic lupus erythematosus (SLE). We propose that SARS-CoV-2-infected patients may develop antibodies against arginine methylated N protein that overlap with self-arginine methylated proteins and lead to autoimmune disease. To test this, we propose performing a series of ELISAs using differentially methylated peptides and plasma from SARS-CoV-2-infected patients. We also plan to perform a series of in vitro methylation assays and mass spectrometry to identify other SARS-CoV-2 proteins modified by PRMTs. These findings will have an impact on why certain patients post-SARS-CoV-2 infection develop persistent illnesses, especially autoimmune diseases. This project will also identify new post-translational modifications that may regulate SARS-CoV-2 biology.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Khan, Sarah M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~